The researchers claimed that activation of toll-like receptor-4 (TLR-4) conferred an antitumor effect on human BMSCs, which were named MSC1; after TLR-3 activation, however, the human BMSCs were converted to MSC2, which promoted tumor growth and metastasis (Waterman et al., 2012). This evidence concerns the gene TLR4 and neoplasm.